Stryker MedSurg and Neurotechnology — Foreign exchange and other remained flat by 0.0% to $21.50M in Q4 2024 compared to the prior quarter. Year-over-year, this metric grew by 152.9%, from $8.50M to $21.50M. Over 3 years (FY 2021 to FY 2024), MedSurg and Neurotechnology — Foreign exchange and other shows an upward trend with a 87.7% CAGR.
An increase in negative impact signals unfavorable currency headwinds, while a decrease or positive value indicates favorable currency tailwinds or neutral conditions.
This metric quantifies the impact of currency fluctuations and miscellaneous non-operational factors on the MedSurg and...
Comparable to 'foreign currency translation impact' or 'FX impact' disclosed by global medical technology companies.
syk_segment_medsurg_and_neurotechnology_foreign_exchange_and_other| FY'21 | FY'22 | FY'23 | FY'24 | |
|---|---|---|---|---|
| Value | -$13.00M | -$54.00M | $34.00M | $86.00M |
| YoY Change | — | -315.4% | +163.0% | +152.9% |
We use cookies for analytics. See our Privacy and Cookie Policy.